Viral interleukin 10 (id10), the human herpes virus 4 cellular ibl0 homologue, induces local anergy to allogeneic and syngeneic tumors

Journal of Experimental Medicine

Volumn 182, Issue 2, 1995, Pages 477-486

  Suzuki, Tadamichi ^a   Tahara, Hideaki ^a   Narula, Satwant ^b   Moore, Kevin W ^c   Robbins, Paul D ^a   Lotze, Michael T ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c IDNAX Research Institute ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; VIRUS VECTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL SURVIVAL; CLONAL ANERGY; EPSTEIN BARR VIRUS; FEMALE; FIBROBLAST; HERPES VIRUS; IMMUNOREACTIVITY; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; RETROVIRUS; SEQUENCE HOMOLOGY; TARGET CELL; TUMOR GROWTH;

ANIMAL; FEMALE; GRAFT REJECTION; HERPESVIRUS 4, HUMAN; IMMUNE TOLERANCE; LYMPHOCYTE SUBSETS; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RECOMBINANT PROTEINS; SPECIES SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFECTION; VIRAL PROTEINS;

EID: 0029100824     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.182.2.477     Document Type: Article

References (50)

1. Fiorentino, D.F., M.W. Bond, and T.R. Mosmann. 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Thl clones. J. Exp. Med. 170: 2081-2095.
2. Moore, K.W., A. O’Garra, R. de Waal Malefyt, P. Vieira, and T.R. Mosmann. 1993. Interleukin 10. Annu. Rev. Immunol. 11: 165-190.
3. Ho, A. S.-Y., and K.W. Moore. 1994. Interleukin 10 and its receptor. Therapeutic Immunology 1: 173-185.
4. Moore, K.W., P. Vieira, D.F. Fiorentino, M.L. Trounstine, T.A. Khan, and T.R. Mosmann. 1990. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRF1. Science (Wash. DC). 248: 1230-1234.
5. Vieira, P., R. de Waal Malefyt, M.N. Dang, K.E. Johnson, R. Kastelein, D.F. Fiorentino, J.E. DeVries, M.G. Roncarolo, T.R. Mosmann, and K.W. Moore. 1991. Isolation and expression of human cytokine synthesis inhibitory factor (CSIF/IL 10) cDNA clones: homology to Epstein-Barr virus open reading frame BCRF1. Proa Natl. Acad. Sci. USA. 88: 1172-1176.
6. Hudson, G.S., A.T. Bankier, S.C. Satchwell, and B.G. Barrell. 1985. The short unique region of the B95-8 Epstein-Barr virus genome. Virology. 147: 81-98.
7. Miyazaki, I., R.K. Cheung, and H.-M. Dosch. 1993. Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus. J. Exp Med. 178: 439-447.
8. Fiorentino, D.F., A. Zlotnik, P. Vieira, T.R. Mosmann, M. Howard, K.W. Moore, and A. O’Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Thl cells. J. Immunol. 146: 3444-3451.
9. Taga, K., and G. Tosato. 1992. IL10 inhibits human T cell proliferation and IL2 production. J. Immunol. 148: 1143-1148.
10. de Waal Malefyt, R., J. Haanen, H. Spits, M.-G. Roncarolo, A. te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J.E. de Vries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174: 915-924.
11. MacNeil, I.A., T. Suda, K.W. Moore, T.R. Mosmann, and A. Zlotnik. 1990. IL-10, a novel growth cofactor for mature and immature T cells. J. Immunol. 145: 4167-4173.
12. Thompson-Snipes, L., V. Dhar, M.W. Bond, T.R. Mosmann, K.W. Moore, and D.M. Rennick. 1991. Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J. Exp Med. 173: 507-510.
13. Go, N.F., B.E. Castle, R. Barrett, R. Kastelein, W. Dang, T.R. Mosmann, K.W. Moore, and M. Howard. 1990. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exp. Med 172: 1625-1631.
14. Elliot, B.E., D.A. Carlow, A. Rodricks, and A. Wade. 1989. Perspectives on the roles of MHC antigens in normal and malignant cell development. Adv. Cancer Res. 53: 181-195.
15. Hui, K., F. Grosveld, and H. Festenstein. 1984. Rejection of transplantable AKR leukemia cells following MHC DNA mediated cell transformation. Nature (Lond.). 311: 750-752.
16. Wallich, R., N. Bulbue, G.J. Hammerling, S. Katzav, S. Segal, and M. Feldman. 1985. Abrogation of metastatic properties of tumor cells by de novo expression of H-2K antigens following H-2 gene transfection. Nature (Lond.). 315: 301-305.
17. Celvic, C., D.A. Lewis, and M.H. Goldrosen. 1983. Demonstration of immunogenicity with the poorly immunogenic B16 melanoma. Cancer Res. 43: 3507-3510.
18. Gorelik, E., Y. Gunji, and R.B. Herberman. 1988. H-2 antigen expression and sensitivity of B16 melanoma cells to natural killer cell cytotoxicity. J. Immunol. 140: 2096-2102.
19. Tanaka, K., E. Gorelik, M. Watanabe, N. Hozumi, and G. Jay. 1988. Rejection of B16 melanoma induced by expression of a transfected major histocompatibility complex class I gene. Mol. Cell. Biol. 8: 1857-1861.
20. Shu, S., and S.A. Rosenberg. 1985. Adoptive immunotherapy of newly induced murine sarcomas. J. Immunol. 135: 2895-2903.
21. Rosenberg, S.A., E. Grimm, M. McGrogan, M. Doyle, E. Kawasaki, K. Koths, and D.F. Mark. 1984. Biologic activity of recombinant human interleukin-2 produced in Escherichia coli. Science (Wash. DC). 223: 1412-1415.
22. Wang, A., S.D. Lu, and D.F. Mark. 1984. Mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues. Science (Wash. DC). 224: 1431-1433.
23. Gately, M.K., and R. Chizzonite. 1992. Measurement of human and mouse interleukin-12. In Current Protocols in Immunology. J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober, editors. Green Publishing and Wiley-Interscience, New York. 6.
24. Tahara, H., G.M. Mueller, C. Ricordi, P.D. Robbins, and M.T. Lotze. 1992. Islet cell transplantation facilitated by gene transfer. Transplant. Proc. 24: 2975-2976.
25. Dranoff, G., E. Jaffee, A. Lazenby, P. Golumbek, H. Levitsky, K. Brose, V. Jackson, H. Hamada, D. Pardoll, and R. Mulligan. 1993. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA. 90: 3539-3543.
26. Zitvogel, L., H. Tahara, G.M. Mueller, S.F. Wolf, M.K.U. Gubler, M.K. Gately, P.D. Robbins, and M.T. Lotze. 1994. Construction and characterization of retroviral vectors expressing biologically active human IL-12. Hum. Gene Therapy. 5:1493-1506.
27. Danos, O., and R.C. Mulligan. 1988. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl. Acad. Sci. USA. 85: 6460-6464.
28. Takebe, Y., M. Seiki, J.-I. Fujisawa, P. Hoy, K. Yokota, K.-I. Arai, M. Yoshida, and N. Arai. 1988. SR-alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol. 8: 466-472.
29. Itoh, T., W.J. Storkus, E. Gorelik, and M.T. Lotze. 1994. Partial purification of murine tumor-associated peptide epitopes common to histologically distinct tumors, melanoma and sarcoma, that are presented by H-2Kb molecules and recognized by CD8+ tumor-infiltrating lymphocytes. J. Immunol. 153: 1203-1215.
30. Chan, S.H., M. Kobayashi, D. Young, and G. Trinchieri. 1992. Mechanisms of IFN-gamma induction by natural killer cell stimulatory factor (NKSF/IL-12): role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J. Immunol. 148: 92-98.
31. Hsieh C.-S, S. Macatonia, C. Tripp, S. Wolf, A. O’Garra, and K. Murphy. 1993. Development of Thl CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science (Wash. DC). 260: 496-497.
32. Erard, F., P. Corthesy, M. Nabholz, J.W. Lowenthal, P. Zaech, G. Plaetinck, and H.R. MacDonald. 1985. Interleukin 2 is both necessary and sufficient for the growth and differentiation of lectin-stimulated cytolytic T lymphocyte precursors. J. Immunol. 134: 1644-1652.
33. Mosmann, T.R., and R.L. Coffmann. 1987. Two types of mouse helper T-cell clone. Immunol. Today. 8: 223-227.
34. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47: 187-199.
35. Grimm, E.A., and S.A. Rosenberg. 1983. The human lymphokine activated killer cell phenomenon. Lymphokines. 9:435-441.
36. D’Andrea, A., M. Aste-Amezaga, N.M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon 7 production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178: 1041-1048.
37. Murphy, E.E., G. Terres, S.E. Macatonia, C.-S. Hsieh, J. Mattson, L. Lanier, M. Wyscoka, G. Trinchieri, K. Murphy, and A. O’Garra. 1994. B7 and interleukin 12 cooperate for proliferation and interferon 7 production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp. Med. 180: 223-231.
38. Tripp, C.S., S.E. Wolf, and E.R. Unanue. 1993. Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl. Acad. Sci. USA. 90:3725-3729.
39. Chen, W.-F., and A. Zlotnik. 1991. Interleukin 10: a novel cytotoxic T cell differentiation factor. J. Immunol. 147: 528-534.
40. Taga, K., B. Chemey, and G. Tosato. 1993. IL-10 inhibits apoptotic cell death in human T cells starved of IL-2. Int. Immunol. 12: 1599-1608.
41. Jinquan, T., C.G. Larsen, B. Gesser, K. Matsushima, and K. Thestrup-Pedersen. 1993. Human interleukin 10 is a chemoattractant for CD8+ T lymphocytes and an inhibitor of IL-8-induced CD4+ T lymphocyte migration. J. Immunol. 151:4545-4551.
42. Wogensen, L., X. Huang, and N. Sarvetnick. 1993. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans. J. Exp. Med. 178: 175-185.
43. Wogensen, L., M.S. Lee, and N. Sarvetnick. 1994. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. J. Exp Med. 179: 1379-1384.
44. Pennline, K.J., E. Roque-Gaffney, and M. Monahan. 1994. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic (NOD) mouse. Clin. Immunol. Immunopathol. 71: 169-175.
45. Ho, A.S.-Y., Y. Liu, T.A. Khan, D.-H. Hsu, J.F. Bazan, and K.W. Moore. 1993. A receptor for interleukin-10 is related to interferon receptors. Proc. Natl. Acad. Sci. USA. 90: 11267-11271.
46. Liu, Y. S.H.-Y. Wei, A.S.-Y. Ho, R. de Waal Malefyt, and K.W. Moore. 1994. Expression cloning and characterization of a human interleukin-10 receptor. J. Immunol. 152: 1821-1829.
47. Xu-Amano, J., Y. Liu, S.H.-Y. Wei, A.S.-Y. Ho, A.K.-H. Hsu, and K.W. Moore. IL-10 receptor (IL-10R) transfectants’ responses to viral IL-10: evidence for additional IL-10R components. FASEB J. 9:772a. (Abstr.)
48. Starzl, T.E., A.J. Demetris, and D. Van Thiel. 1989. Liver transplantation. N. Engl. J. Med. 321: 1014-1022.
49. Starzl, T.E., A.J. Demetris, M. Trucco, N. Murase, C. Ricordi, S. Ildstad, H. Ramos, S. Todo, J.J. Fung, M. Nalesnik, et al., 1993. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology. 17:1127-1152.
50. Richter, G., S. Kruger-Rrasagakes, G. Hein, C. Huls, E. Schmitt, T. Diamantstein, and T. Blankenstein. 1993. Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res. 53: 4134-4137.